ALDH1A3
ALDH1A3 is a gene that encodes the enzyme aldehyde dehydrogenase 1 family member A3. This enzyme is part of the aldehyde dehydrogenase family, a group of enzymes that metabolize aldehydes into their corresponding acids. ALDH1A3 is particularly important in the retinoic acid synthesis pathway, which plays a crucial role in vertebrate development.
Function[edit]
The ALDH1A3 enzyme is involved in the oxidation (dehydrogenation) of retinaldehyde to retinoic acid. Retinoic acid is a metabolite of vitamin A that mediates the functions of vitamin A required for growth and development. ALDH1A3 is primarily expressed in the ventral region of the neural tube, and is involved in the early stages of central nervous system development.
Clinical significance[edit]
Mutations in the ALDH1A3 gene have been associated with a number of disorders. These include microphthalmia, a condition characterized by abnormally small eyes, and anophthalmia, the absence of one or both eyes. Both of these conditions can lead to significant vision loss. Mutations in ALDH1A3 have also been linked to coloboma, a condition where normal tissue in or around the eye is missing at birth.

See also[edit]
References[edit]
| Genes on human chromosome 15 | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This human genetics related article is a stub.
|
| Aldehyde dehydrogenases (EC 1.2.1) | ||||||||
|---|---|---|---|---|---|---|---|---|
|
| Eye development genes | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
This eye development related article is a stub.
|
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian